- Home
- LIEN vs QTRX Comparison
LIEN vs QTRX Comparison
Compare LIEN & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIEN
- QTRX
- Stock Information
- Founded
- LIEN 2021
- QTRX 2007
- Country
- LIEN United States
- QTRX United States
- Employees
- LIEN N/A
- QTRX N/A
- Industry
- LIEN
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- LIEN
- QTRX Industrials
- Exchange
- LIEN NYSE
- QTRX Nasdaq
- Market Cap
- LIEN 234.6M
- QTRX 233.5M
- IPO Year
- LIEN 2022
- QTRX 2017
- Fundamental
- Price
- LIEN $10.09
- QTRX $5.33
- Analyst Decision
- LIEN Buy
- QTRX Buy
- Analyst Count
- LIEN 2
- QTRX 5
- Target Price
- LIEN N/A
- QTRX $15.60
- AVG Volume (30 Days)
- LIEN 44.6K
- QTRX 678.8K
- Earning Date
- LIEN 05-14-2025
- QTRX 05-12-2025
- Dividend Yield
- LIEN 13.49%
- QTRX N/A
- EPS Growth
- LIEN 30.25
- QTRX N/A
- EPS
- LIEN 1.15
- QTRX N/A
- Revenue
- LIEN $30,828,508.00
- QTRX $135,688,000.00
- Revenue This Year
- LIEN $132.36
- QTRX N/A
- Revenue Next Year
- LIEN $5.67
- QTRX $14.75
- P/E Ratio
- LIEN $8.74
- QTRX N/A
- Revenue Growth
- LIEN 151.96
- QTRX 7.71
- 52 Week Low
- LIEN $9.71
- QTRX $4.05
- 52 Week High
- LIEN $13.38
- QTRX $19.18
- Technical
- Relative Strength Index (RSI)
- LIEN N/A
- QTRX 51.56
- Support Level
- LIEN N/A
- QTRX $5.10
- Resistance Level
- LIEN N/A
- QTRX $5.60
- Average True Range (ATR)
- LIEN 0.00
- QTRX 0.32
- MACD
- LIEN 0.00
- QTRX 0.10
- Stochastic Oscillator
- LIEN 0.00
- QTRX 81.71
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company is an externally managed, closed-end, non-diversified management investment company with an investment objective to maximize risk-adjusted returns on equity for its stockholders by investing in direct loans to privately held middle-market companies, with a focus on cannabis companies.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.